Skip to main content Back to Top

Establishing Infrastructure to Develop Pharmacy Population Health and Service Line Payer Engagement

Broadcast Date: August 17, 2022


Subscribe on iTune PodcastsListen on Google PlaySubscribe to Stitcher Podcasts Listen on Spotify Subscribe to TuneIn PodcastsSubscribe to iHeartRadio

This podcast will discuss strategies to develop pharmacy practice infrastructure in population health and service line settings, discuss options to measure this practice success on patient outcomes, and opportunities to utilize this data in organizational payer engagement.


Amanda BrummelAmanda Brummel, PharmD, BCACP serves as the Vice President of Clinical Ambulatory Pharmacy Services. Dr. Brummel has been employed by Fairview Pharmacy Services since 1999 when she graduated from the University of Minnesota. Dr. Brummel has responsibility for the MTM Program, the Anticoagulation Program, the Outcomes department, Compliance department and the clinical development and integration of ambulatory pharmacy services in the MHealth Fairview Network. Dr. Brummel is also an Adjunct Professor at the University of Minnesota.

Lindsey AmerineLindsey B. Amerine, PharmD, MS, BCPS, FASHP, is System Executive Director of Pharmacy for UNC Health, Coordinator for the HSPAL Residency, and an Associate Professor of Clinical Education at the UNC Eshelman School of Pharmacy (ESOP). Dr. Amerine earned her Doctor of Pharmacy degree from the University of Wyoming School of Pharmacy and her Master of Science degree with an emphasis in Health-System Pharmacy Administration from the UNC ESOP while completing her two-year HSPA Residency at UNC Hospitals.

Ryan NasemanRyan Naseman, PharmD, MS, BCPS, is Sr. Director of Acute Care Pharmacy Services at the University of Kentucky HealthCare in Lexington, Kentucky. Where he is responsible for all hospital based pharmacy operations and clinical services across the 1040 bed, two-hospital system and 65 hospital-based clinics, as well as compliance of the enterprise 340b program.

The information presented during the podcast reflects solely the opinions of the presenter. The information and materials are not, and are not intended as, a comprehensive source of drug information on this topic. The contents of the podcast have not been reviewed by ASHP, and should neither be interpreted as the official policies of ASHP, nor an endorsement of any product(s), nor should they be considered as a substitute for the professional judgment of the pharmacist or physician.